Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Abrau-Durso and Magnit will take care of candies

12/19/23 ABRD

Magnit began production of sweets under the wine brand

12/19/23 MGNT

Nornickel entered the stainless steel project

12/19/23 GMKN

SGC will work to increase capitalization

12/19/23 UGLD

EU imposed a ban on all Russian diamonds

12/19/23 ALRS

Shareholders of Gazprom Neft approved dividends

12/18/23 SIBN

Kazanorgsintez sold its pipe production facility

12/18/23 KZOS

Sovcomflot transferred half of its conventional fleet to long-term contracts

12/18/23 FLOT

IMCB to conduct stock split

12/18/23 GEMA

MD Medical will allocate up to 100% of profits to dividends

12/18/23 MDMG